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ABSTRACT Host genetic variation is known to contribute to differential pathogenesis following infection.
Mouse models allow direct assessment of host genetic factors responsible for susceptibility to Severe Acute
Respiratory Syndrome coronavirus (SARS-CoV). Based on an assessment of early stage lines from the Collab-
orative Cross mouse multi-parent population, we identified two lines showing highly divergent susceptibil-
ities to SARS-CoV: the resistant CC003/Unc and the susceptible CC053/Unc. We generated 264 F2 mice
between these strains, and infected them with SARS-CoV. Weight loss, pulmonary hemorrhage, and viral
load were all highly correlated disease phenotypes. We identified a quantitative trait locus of major effect
on chromosome 18 (27.1–58.6 Mb) which affected weight loss, viral titer and hemorrhage. Additionally,
each of these three phenotypes had distinct quantitative trait loci [Chr 9 (weight loss), Chrs 7 and 12 (virus
titer), and Chr 15 (hemorrhage)]. We identified Ticam2, an adaptor protein in the TLR signaling pathways,
as a candidate driving differential disease at the Chr 18 locus. Ticam22/2 mice were highly susceptible to
SARS-CoV infection, exhibiting increased weight loss and more pulmonary hemorrhage than control mice.
These results indicate a critical role for Ticam2 in SARS-CoV disease, and highlight the importance of host
genetic variation in disease responses.
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Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV)
emerged in 2002–2003 as the first highly pathogenic zoonotic virus
of the 21st century (Ksiazek et al. 2003). During the outbreak, over
8000 people were infected with SARS-CoV (https://www.cdc.gov/sars/
about/fs-sars.html), and these individuals experienced disease pheno-
types ranging from mild respiratory symptoms to severe pulmonary
disease including diffuse alveolar damage (DAD), acute respiratory
distress syndrome (ARDS), and death (10% mortality rate). More re-
cently, a close relative to SARS-CoV, designated Middle East Respira-
tory Syndrome-CoV (MERS-CoV) was identified from a patient
hospitalized with pneumonia in Saudi Arabia (Zaki et al. 2012). Since
2012,.1850MERS cases (http://www.who.int/emergencies/mers-cov/
en/) have been identified, with sporadic cases still appearing in the
Middle East. MERS-CoV infection has a 35% mortality rate, making
it the second highly pathogenic human coronavirus, and supporting
the hypothesis that emerging coronaviruses threaten global health.
Additionally, a large number of SARS-like coronaviruses have been
identified in geographically diverse bat populations, highlighting the
potential for related pathogens to emerge into the human population
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(Ge et al. 2013; Menachery et al. 2015; Yang et al. 2015; Kim et al. 2016;
Menachery et al. 2016). While SARS-CoV and MERS-CoV both cause
significant morbidity and mortality, the limited scope of the outbreaks
greatly restricted our understanding of the host and viral factors that
contribute to coronavirus-induced disease.
Given the sporadic nature of emerging disease outbreaks, new
strategies are needed to identify host genetic variants that regulate
disease severity and susceptibility. Host genetic variation contributes
to susceptibility to many infectious diseases in human populations
(Chapman andHill 2012;Manry andQuintana-Murci 2013), including
SARS-CoV (Ip et al. 2005; Zhang et al. 2005; Chen et al. 2006). How-
ever, inability to control for important confounding factors—including
dose, route of infection, various comorbidities (age, weight, etc.), and
baseline immune state of the host—complicate interpretation of
genome-wide association studies in human populations. While these
complex factors are often unknown in human infections, small animal
models of disease allow for controlled experiments to dissect the influ-
ence of such variables, and have greatly expanded our understanding of
SARS-CoV pathogenesis (Roberts et al. 2005a,b, 2007). Candidate gene
approaches and careful analysis of the host immune response to in-
fection (Frieman et al. 2007; Sheahan et al. 2008; Zhao et al. 2011;
Totura et al. 2015) have revealed the importance of a number of clas-
sical aspects of both the innate and adaptive immune response in
facilitating aspects of SARS-CoV protection and disease enhancement.
In addition, predictive systems approaches have highlighted less obvi-
ous aspects, such as wound-repair, in influencing host outcomes fol-
lowing SARS-CoV infection (Gralinski et al. 2013).
Patternrecognitionreceptors (PRRs), suchas toll-like receptors (TLRs),
complement receptors, andRIG-I-like receptors trigger the innate immune
response to respond to pathogens (Adachi et al. 1998; Poltorak et al. 1998;
Alexopoulou et al. 2001; Akira et al. 2006; Kawai and Akira 2009;
Dunkelberger and Song 2010). PRRs recognize foreign molecules in the
cytoplasm, endosome, or at the cell surface specific to invading pathogens
such as lipopolysaccharide (LPS), flagellin, and double strandedRNA.Not
all identified PRRs have known ligands (Oosting et al. 2014), and new
PRRs and ligands are still being discovered. SARS-CoV infection is sensed
by TLR3 and TLR4 (Totura et al. 2015), and SARS-CoV actively evades
detection of its cytosolic RNA byMDA5 through the 29methyltransferase
activity of the viral nsp16 protein (Menachery et al. 2014). Furthermore,
numerous SARS-CoV genes block interferon sensing and signaling
(Kopecky-Bromberg et al. 2007; Frieman et al. 2009; Clementz et al.
2010) among other immune evasion strategies. Candidate gene studies
of PRRs or other immune factors in inbred mouse strains typically use
genetic knockouts, which are rare in natural populations, and do not
reflect natural genetic variation. Incongruent disease phenotypes have also
been observed when gene knockouts are analyzed on the background of
different inbred strains (Bonyadi et al. 1997; Linder 2006; Barbaric et al.
2007; Ramsbottom et al. 2015), thus complicating the interpretation of
those results to outbred populations like humans. Functional knockouts in
human immune genes are unusual but do exist (Godowski et al. 1989;
Greenberg et al. 1991; Conrad et al. 2006; Knight 2013).CCR5D32 is a rare
example of a nonfunctional gene being advantageous, leading to its spread
throughout the population (Novembre et al. 2005).More commonly, such
mutations are found to have deleterious effects, such as in the case ofTLR3
deficiency leading to susceptibility to Herpes Simplex Virus 1 - induced
encephalitis (Zhang et al. 2007), IRAK-4 deficiency resulting in suscepti-
bility to bacterial infections (Picard et al. 2003), or the CDK4 deletions
found in cancer patients (Nobori et al. 1994). More relevant for hu-
man disease is the impact of functional allelic variation in both coding
and noncoding regions of genes, which the Collaborative Cross (CC) is
designed to model.
Inbred mouse strains have represented the gold standard in animal
model development, designed primarily to minimize experimental vari-
ables in a mammalian system (Chung et al. 1997; Rosenthal and Brown
2007; Vandamme 2014). However, the limited genetic variation segregat-
ing among classical inbred strains such as C57BL/6 and Balb/c and their
convoluted ancestry limits their use for genetic association studies
(Williams et al. 2004; Yang et al. 2007, 2011). In recent years, there has
been a growing appreciation for the importance of genetic variation be-
tween individuals in contributing to a number of disease states including
autoimmune diseases, Alzheimer’s disease and general immunodeficiency
(Rebeck et al. 1993; Schmalstieg and Goldman 2002; Lee et al. 2013). The
CC is a multi-parent population (MPP) of recombinant inbred strains
created to assess and identify genetic variants driving complex disease, while
concurrently maintaining the reproducibility andmanipulative potential of
inbred strains (Threadgill et al. 2011; Threadgill andChurchill 2012b). Each
CC strain is a unique mosaic of eight founder haplotypes—A/J, C57BL/6J,
129S1/SvImJ, NOD/ShiLtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ and WSB/
EiJ—representing all three subspecies of housemouse;.40 million genetic
variants segregate in the CCpopulation (Keane et al. 2011) (Srivastava et al.
2017) (Oreper et al. 2017). Recently, a wealth of information on the ge-
netic architecture of immune responses and viral disease pathogenesis has
been identified in populations related to the CC (Durrant et al. 2011;
Ferris et al. 2013; Phillippi et al. 2014; Xiong et al. 2014; Graham et al.
2015; Gralinski et al. 2015; Graham et al. 2016)(Green et al. 2017). We
previously identified numerous host genetic loci that contribute to SARS-
CoV pathogenesis using a screen of the incipient lines of the CC (the
preCC) (Gralinski et al. 2015).
Here, we extend our work from the preCC population to an F2 cross
between two inbred CC strains showing extreme divergent responses to
SARS-CoV (Gralinski et al. 2015), the first F2 study of infectious disease
between two CC lines. In contrast to QTL mapping across a genetic
reference population, focused F2 crosses allow for a more complete
dissection of extremely divergent phenotypic responses between pairs
of strains, an approach that can highlight multi-genic and complex in-
teractions in a more focused (and powered) contrast. The phenotypic
distribution for each SARS-CoV response trait we measured equaled or
exceeded the distribution seen between the two parent strains of the F2,
and the phenotypes were broad (over a four log range in viral titer levels
and.30% difference in weight loss in response to infection). Quantita-
tive trait loci (QTL) mapping identified five significant loci contributing
to weight loss, virus titer, pulmonary hemorrhage, and histopathology
phenotypes, and we found evidence for both additive and epistatic inter-
actions between these loci. AQTL affectingmultiple SARS-CoV response
traits on chromosome 18 from 27.1–58.6 Mb that contributed between
6 and 12% of each phenotype was selected for further study. Bioinfor-
matics analysis reduced the number of candidate genes in the QTL re-
gion, leading to prioritization of Ticam2 for candidate gene studies. We
confirmed that Ticam2, a TLR adapter protein specific to TLR4, contrib-
utes to SARS-CoV pathogenesis by showing that Ticam22/2 mice have
increased susceptibility to SARS-CoV infection. By using CC lines with
extreme SARS-CoV response phenotypes, we may have enriched for
extreme alleles selected from different pairs of founders at each causative
locus. Our data reaffirms use of F2 crosses as a powerful strategy to
identify novel genetic variants that regulate extreme disease phenotypes
following virus infection in the CC resource population.
MATERIALS AND METHODS
Virus and cells
Recombinant mouse-adapted SARS-CoV (MA15) was propagated on
Vero E6 cells. For virus titration, the lower half of the right lung was
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homogenized in PBS and plated for plaque assay using Vero E6 cells to
give plaque forming units (PFU) per lung with a detection limit of
100 PFU (Deming et al. 2006). All experiments were performed in a
class II biological safety cabinet in a certified biosafety level 3 labora-
tory containing redundant exhaust fans by workers wearing personnel
protective equipment, including Tyvek suits, hoods, and high-efficiency
particulate air (HEPA)-filtered powered air-purifying respirators
(PAPRs).
Animals
PreCCmicewere infectedandassayedasdescribedpreviously (Gralinski
et al. 2015). CC003/Unc and CC053/Unc mice were obtained from the
UNC Systems Genetics Core. F1 and F2 mice were bred in house from
these two parent lines, and infected at 9–11 wk of age. Both male and
femalemice were used for F1 and F2 studies, while the preCC used only
female mice. F2 mice were identified by earpunch and randomly
cohoused at the time of weaning; a tail snip for DNA extraction was
also taken at that time. Ticam2-deficient mice on a C57BL/6 back-
ground were obtained from the Heise laboratory (UNC), originally
created by Yamamoto et al. (2003). All mice were anesthetized with a
mixture of ketamine and xylazine, intranasally infected with 105 PFU of
MA15 in a 50 ml volume, and weighed daily. Mice were acclimated to
BSL3 housing for a minimum of 7 d prior to infection. All mouse
studies were performed at the University of North Carolina (Animal
Welfare Assurance #A3410-01) using protocols approved by the UNC
Institutional Animal Care and Use Committee (IACUC).
Histological analysis and hemorrhage
Grosspulmonaryhemorrhagewasobservedat the timeof tissueharvest,
and scored on a scale of 0 (nohemorrhage in any lobe) to 4 (extreme and
complete hemorrhage in all lobes of the lung). Lung tissues for histo-
logical analysis were fixed in 10% formalin for at least 7 d, embedded in
paraffin, and 5-mm sections were prepared by the UNC histopathology
core facility. To determine the extent of inflammation, sections were
stained with hematoxylin and eosin (H&E), and scored in a blinded
manner as previously described (Gralinski et al. 2013).
DNA isolation and genotyping: Genomic DNA was isolated from tail
tissue using the Qiagen (Hilden, Germany) DNeasy Blood & Tissue kit
protocol, and was quantified and assessed for purity using a Nanodrop
instrument (Thermo-Fisher Scientific). Genomic DNA (1.5 mg) was
sent from each animal to Neogen Inc. (Lincoln, NE) for array hybrid-
ization on the MUGA array (Morgan et al. 2015). Genotypes were called
by the vendor using the GenCall algorithm implemented in the Illumina
BeadStudio software. Quality checks and further analysis used the argyle
package (Morgan 2015) for the R environment (www.cran.r-project.org).
QTL mapping: We selected those SNP markers behaving in a biallelic
manner between replicate samples of CC003/Unc and CC053/Unc
(Threadgill and Churchill 2012a), and, using the argyle package, we
used the thin.genotypes() function to arrive at a set of 304 biallelic
markers evenly spaced across the genome for QTL mapping. We
exported these data into the R/QTL (Arends et al. 2010) package using
argyle’s as.rqtl.genotypes() function, and mapped QTL for each of the
measured phenotypic traits using the scanone() function in rqtl. Spe-
cifically, the scanone() function fits a model:
yi ¼ mþ Bxi þ e
where yi is the phenotypic value of individual i, m is the population
mean, xi is the genotype at a putative QTL, and e is the error term,
with Β being the estimated effect of transitioning from one allele to
another at the putative QTL. Scanone() uses standard interval map-
ping (Lander and Botstein 1989) to assess the significance of fit of this
model relative to the null model:
yi ¼ mþ e:
Significance was assessed for each phenotype using 500 permutations.
QTL regions were denoted using a 1.5 LOD-drop method.
We next utilized the scantwo() function of R/QTL to assess the
likelihood of higher order interactions between pairs of loci. Scantwo()
fits a series of models looking at the fit of two loci as a full model:
yi ¼ mþ Bax1i þ Bbx2i þ Bcfx1i  x2ig þ e
where x1i and x2i are the genotypes at two putative loci, and x1ix2i is a
representation of the combination of these two genotypes. In this
case, Ba is the estimated effect of transitioning between alleles at
putative locus 1, Bb the estimated effect of transitioning between
alleles at putative locus 2, and Bc is the estimated interaction effect
of transitioning between alleles within each locus. Scantwo() also
assesses the fit of an additive model:
yi ¼ mþ Bax1i þ Bbx2i þ e
Both of these models, as well as a pure-interaction model (Full model
fit-Additive model fit) are then assessed relative to a null model:
yi ¼ mþ e:
Significance in these situations was assessed using a total of 250
permutations.
Statistical analysis: SARS-CoV F2 phenotypes were compared by
Pearson correlation using Graphpad Prism, and raw P-values are re-
ported. Ticam22/2 and C57BL/6J phenotypes were compared by un-
paired Student’s t-test. The percentage of phenotypic variation each
QTL contributed (as reported in Table 1) were assessed using the
lm() function in R, and determining the SSgenotype/SStotal fraction at
each peak marker at a QTL.
n Table 1 QTL regions and statistics
QTL Trait(s) Chromosome Start (Mb) Max (Mb) and Marker Stop (Mb) Percent Variation Explained (%)
HrS5 D3% weight Chr 18 27.108062 42.852536 backupUNC181069094 58.694005 6.60
D4% weight 27.108062 51.250937 JAX00083358 58.694005 8.50
Log titer 27.108062 51.250937 JAX00083358 58.694005 12.90
Hemorrhage 24.762824 51.250937 JAX00083358 78.29634 6
HrS6 D3% weight Chr 9 116.476207 121.771517 backupJAX00708075 Telomere 7
HrS7 Log titer Chr 7 55.169841 96.668697 UNC070369595 117.22358 12.30
HrS8 Log titer Chr 12 81.649471 88.541688 UNC120199018 108.529109 5.40
HrS9 Hemorrhage Chr 15 Centromere 30.785867 UNC150077326 64.430001 9.10
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Data availability
Complete F2 phenotypes, along with the subset of genotypic markers
used for mapping, are available in Supplemental Material, Table S1. F1
and Ticam22/2 data are available in Table S3. Genotype data are avail-
able at Zenodo (DOI 10.5281/zenodo.401060) and also at http://www.
med.unc.edu/mmrrc/genotypes/. QTL outputs for D3 weight loss, D4
weight loss, Log10 Titer, and hemorrhage are available in Table S4,
Table S5, Table S6, and Table S7.
RESULTS
We selected two CC strains (CC003/Unc and CC053/Unc) which (a)
had shown extreme and divergent SARS-CoV responses in our preCC
study (Gralinski et al. 2015), and (b)were available as completely inbred
stains at the time we initiated this study [many preCC strains went
extinct during the inbreeding process (Shorter et al. 2017)]. PreCC
funnel 3067, now the fully inbred line CC003/Unc, was highly resistant
to SARS-CoV-induced weight loss (Figure 1A), despite having a high
viral load in the lung at 4 d postinfection (Figure 1B). In contrast,
preCC funnel 773, now the fully inbred line CC053/Unc, was highly
susceptible to SARS-CoV infection, exhibiting extreme weight loss and
mortality, but a low virus load in the lung. From CC003/Unc and
CC053/Unc, we bred reciprocal F1 mice to test for susceptibility to
SARS-CoV infection. Both male and female F1 mice were intranasally
infected with 105 PFU of mouse-adapted SARS-CoV (MA15). All F1
animals showed intermediate weight loss and titer phenotypes (Figure
1, C andD and raw data in Table S2), and these phenotypes were highly
similar regardless of the cross order. Together, the results suggested that
genetic elements driving susceptibility and resistance in parental lines
were not dominant, not dependent on parent of origin, and could be
mapped in an F2 cross.
Infected F2 progeny produce a range of disease
F1 mice were bred to generate 264 F2 mice for challenge with SARS-
CoV. All mice were infected with 105 PFU of mouse-adapted SARS-
CoV (MA15) at 9–11 wk of age, and monitored daily for weight loss
and signs of disease until harvest at 4 d postinfection. Unlike the F1
mice, which had a narrow range of disease, F2 mice showed ex-
panded phenotypes, exceeding both the range of weight loss and
titer observed in the parents (Figure 2). Two percent (4/264) of F2
mice gained weight over the course of the 4 d infection, and an
additional 41% (108/264) of F2 animals lost 0–10% of their starting
weight, marking them as relatively resistant to infection (Figure 2A).
Thirty-seven percent (99/264) of animals were moderately suscep-
tible, losing between 10 and 20% of their starting weight by day 4
postinfection. Twenty percent of animals were extremely suscepti-
ble to infection, losing either over 20% of their starting weight (12%,
33/264) or succumbing to infection (8%, 20/264). Notably, 28% of
F2 mice showed transient weight loss, and began to recover from
infection by day 4; they are represented in both the 0–10% and 10–
20% weight loss groups. Overall, the weight loss results highlight the
range and diversity of the F2 progeny’s host response to SARS-CoV
infection.
In addition to weight loss, other markers of pathogenesis dem-
onstrate the variability of the F2 response to SARS-CoV. Lung titers
were assessed by plaque assay for all surviving F2 mice, and titers
ranged from,103 PFU per lung to.107 PFU per lung (Figure 2B).
Notably, significant correlation was observed between weight loss
and titer (Pearson’s r 20.5553, P , 0.0001, Figure 2C) at day 4
postinfection. Both male and female F2 mice had similar ranges of
weight loss and virus load in the lung (Figure S1); in addition, both
showed significant correlations between the two phenotypes. Pul-
monary hemorrhage was assessed at the time of tissue harvest,
and illustrated a spectrum of disease. F2 mice ranged from no hem-
orrhage (85 mice with a score of zero) (Figure 2D) to extreme
hemorrhage (42 mice with a score of 3 or 4). Hemorrhage was
significantly correlated with both day 4 weight loss (r of 20.699,
P, 0.0001) and titer (r of 0.487, P, 0.0001). Table S1 contains the
full phenotypic data for all F2 mice including lung histopathology
scoring.
Mapping F2 phenotypes reveals multiple QTL
F2miceweregenotypedusing theMUGAarray, andwe conductedQTL
mappingusing304evenlyspacedand informativemarkersusingR/QTL
(Arends et al. 2010). We identified five QTL associated with a variety of
traits: one locus on Chr18 (Host response to SARS QTL #5, Hrs5) was
associated with weight loss at day 3 and day 4 postinfection, viral titer,
pulmonary hemorrhage (Figure 3), vascular cuffing, and edema histo-
pathology phenotypes (Figure S2). Trait-specific QTL were also iden-
tified for day 3 weight loss (Hrs6 Chr 9), viral titer (Hrs7 Chr 7, Hrs8
Chr 12), and hemorrhage (Hrs9 Chr 15). Analysis of the chromosome
Figure 1 preCC parent and F1 phenotypes.
preCC mice from lines 3067 (n = 1) and
773 (n = 2) were infected with 105 PFU of
MA15 and followed for overall pathogenesis
as measured by weight loss relative to day
zero (A) and virus titer in the lung at day four
(B). Two animals from line 773 were received;
however, one succumbed to infection at
day 3 postinfection. Weight loss (C) and titer
(D) were tested in reciprocal F1 mice
[CC003·CC053 (n = 7 for WL and n = 4
for titer) and CC053·CC003 (n = 14 for WL
and n = 12 for titer)].
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18multi-trait QTL indicated a phenotypic contribution of 6.6% of day
3 weight loss, 8.5% of day 4 weight loss, 12.9% of variation in viral titer,
6% of hemorrhage, and a consensus region of 27.1–58.6 Mb (all QTL
are summarized in Table 1). Table S4, Table S5, Table S6, and Table S7
show the complete QTL mapping files, with the LOD score at each of
the 304 markers used.
Given the number of loci segregating within this cross, we next
assessed if therewas evidenceof epistatic interactions between these loci.
We found strong support for additive interactions between Hrs5 and
Hrs6 for day 3 weight loss (LOD = 8.27, genome-wide P = 0.05
threshold = 6.25), and also between Hrs5 and Hrs9 for hemorrhage
(LOD = 9.43, genome-wide P = 0.05 threshold = 6.4). We found
evidence for a full model of interaction (that is both additive and
epistatic interactions) for viral titers betweenHrs7 andHrs8 (LOD = 13.3,
genome-wide P = 0.05 threshold = 11.4), as well as between Hrs7
and Hrs5 (LOD = 17.5, genome-wide P = 0.05 threshold = 11.4)
(Figure 4).
We determined which ancestral (CC founder strain) alleles were
segregating at eachQTL inorder tobetter understand the architecture of
the QTL and SARS-CoV-associated responses we identified. Through-
out the Hrs5 region, CC003/Unc has a PWK-derived allele, whereas
CC053/Unc had a PWK (27.1–31.2 Mb), and then a C57BL/6J (31.2–
51) or a C57BL/6J and 129s1/SvImJ (51–58.6Mb) region of uncertainty
(Figure S3). The shared PWK/PhJ haplotype at the proximal end of the
locus functionally reduced the QTL region to 31.2–58.6 Mb, and, at the
most highly associated marker (JAX00083358, Chr18:51.41 Mb), we
found that the CC003/Unc PWK-derived allele was associated with
enhanced disease relative to the CC053/Unc C57BL/6J-derived
allele—a case of transgressive segregation (Figure 5). Hrs6 had the
CC003/Unc haplotype (C57BL/6J) associated with reduced weight loss
as compared to the CC053/Unc haplotype (WSB/EiJ).Hrs7 showed the
CC003/UNC haplotype (PWK/PhJ 55.1–69 Mb; C57BL/6J 69–78 Mb;
129s1SvImJ 78–90Mb; C57BL/6J and 129s1/SvImJ 90–117.22Mb) was
associated with reduced viral titers as compared to the CC053/Unc
haplotype (C57BL/6J and WSB/EiJ uncertainty 55.1–58 Mb; WSB/
EiJ and PWK/PhJ uncertainty 58–81 Mb; WSB/EiJ 81–117.22 Mb).
Hrs8 had the CC003/Unc haplotype (NOD/ShiLtJ) associated with
lower viral titers than the CC053/UNC haplotype (WSB/EiJ 81.6–
88.9 Mb; WSB/EiJ and CAST/EiJ uncertainty 88.9–108 Mb). Lastly,
Hrs9had theCC003/Unchaplotype (PWK/PhJ centromere–30 Mb,NZO/
Hilt and PWK/PhJ uncertainty 30–36 Mb, PWK/PhJ 36–64.4 Mb)
associated with lower pulmonary hemorrhage as compared to the
CC053/Unc haplotype (NOD/ShiLtJ centromere–22.3 Mb; 129s1/
SvImJ 22.3–32.2 Mb; CAST/EiJ 32.2–64.4 Mb).
Ticam2 plays a critical role in SARS-CoV pathogenesis
Given these haplotypic differences, we compared the PWK andC57BL/
6J genomes on chromosome 18 from 31.2–58.6 Mb, looking for mis-
sense mutations or insertions/deletions to narrow potential candidate
genes beneath the QTL. While it is possible that a spontaneous muta-
tion in either CC003/Unc or CC053/Unc is the cause of Hrs5, we
considered this to be the less likely scenario, and focused our initial
bioinformatics analysis based on genotyping of the CC founder lines.
Using the publically available Sanger sequences (Oreper et al. 2017), we
identified 743 missense mutations but no insertions or deletions in the
consensus region encompassing 158 coding genes (Table S3). Further
examination revealed that four of the missense mutations were located
within Ticam2, formerly known as TRAM—a TLR adapter protein.
Previous work by our group identified critical roles for the TLR path-
ways and adaptors in modulating SARS-CoV disease (Sheahan et al.
2008; Totura et al. 2015), and led us to further pursue the role ofTicam2
in contributing to SARS-CoV pathogenesis. Although knockout mice
do not test the effect of allelic variation in candidate genes, they can
confirm the overall importance of a given gene in phenotypes of
interest. In this case, Ticam2-deficient mice (Ticam22/2) had
greater SARS-CoV induced weight loss than C57BL/6J control mice
(Figure 6A and raw data in Table S2) [and as previously described
(Totura et al. 2015)]. While Ticam22/2mice had similar virus titers
to C57BL/6J control mice at day 4 postinfection [(Totura et al.
2015) and further confirmed in data not shown], their virus load
is significantly higher at day 2 postinfection (Totura et al. 2015).
We further examined Ticam22/2 mice for the additional pheno-
types that mapped to the same region of chromosome 18. Initially
focusing on vascular cuffing, Ticam22/2 mice showed no notable
increase in scoring relative to wild-type control mice despite their
increased weight loss (Figure 6B). In contrast, pulmonary hemorrhage
scores were significantly higher inTicam22/2mice at 4 d postinfection
(Figure 6C). Overall, these data demonstrate an important role for
Figure 2 F2 phenotypes. F2 mice were infected
with 105 PFU of MA15 and monitored for 4 d.
Percent starting weight as measured at day 4 is
shown in (A) and virus titer is shown in (B). A
significant correlation was observed between
weight loss and titer as shown in (C). Pulmonary
hemorrhage was scored at the time of harvest
and is shown in (D).
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Ticam2 in SARS-CoV pathogenesis, although additional loci contribute
to variation in disease severity.
DISCUSSION
Genetic reference panels, especially those MPPs with multiple founder
strains, have increasingly been seen as a rich tool for understanding
mammalian disease states and biomedically important traits in the
context of naturally occurring genetic variation (Nedelko et al. 2012;
Rasmussen et al. 2014; Rogala et al. 2014). In contrast to previous
genetic mapping studies using the entire CC population (Ferris et al.
2013; Gralinski et al. 2015), we focused on two strains exhibiting ex-
treme responses to SARS-CoV infection, predicting that they would
have multiple QTL driving these extreme responses. Further, we hy-
pothesized that each of those QTL would contrast alleles from unique
pairs of founder haplotypes (as these susceptibility responses are out-
side the range of responses seen in other inbred strains). Our study
found five QTL impacting SARS-CoV disease responses in this cross.
Although each locus in an F2 cross can only contrast two haplotypes;
Figure 3 SARS QTL. QTL analysis using the F2 phenotypes and genotypes revealed multiple QTL. The dashed line indicates a significance value
of 0.05 as determined by permutation test.
Figure 4 Interactions between loci driving viral titer responses. (A) Interactions between HrS7 and HrS8. (B) Interactions between HrS7 and HrS5.
In both figures, the y-axis is viral titers (log10), while the x-axis shows the HrS7 genotype (A/A= CC003 homozygous A/B is heterozygous, B/B is
CC053 homozygous). Within each x-axis class the genotypes of HrS8 (A) or HrS5 (B) are binned left to right (CC003/CC003; CC003/CC053;
CC053/CC053).
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across these five loci were components of seven of the eight CC founder
strains, with most contrasting alleles being between classical laboratory
haplotypes vs. one of the wild-derived inbred founder haplotypes. Our
approach highlights the utility in combining novel genetic reference
populations with classical F2 crosses in order to more fully probe the
complex genetic architecture of disease responses.
Our results also demonstrate the importance ofTicam2 in control of
multiple aspects of SARS-CoV pathogenesis such as weight loss, viral
titer, and pulmonary hemorrhage (Figure 6, (Totura et al. 2015)).While
we did not observe any changes in vascular cuffing in Ticam22/2mice
relative to C57BL/6J controls, this is likely due to the complexity of
confirming functional allelic variation in a knockout mouse model.
Ticam2—a TLR sorting adapter protein—recruits the signaling
adapter protein TRIF to mediate TLR4 signaling (Fitzgerald et al.
2003; Oshiumi et al. 2003). While the ligand that activates TLR4 sig-
naling following SARS-CoV infection has not yet been identified, our
group has recently shown that TLR4 deficient mice are highly suscep-
tible to SARS-CoV infection (Totura et al. 2015). Other laboratories
have demonstrated the importance of TLRs in the host immune re-
sponse to porcine epidemic diarrhea virus (PEDV) (Cao et al. 2015)
and mouse hepatitis virus (Mazaleuskaya et al. 2012), supporting a
general requirement for TLR signaling in an effective immune response
to coronavirus infection. TLR4 is classically known as the LPS receptor
(Poltorak et al. 1998), but it can also recognize host proteins that have
altered expression under conditions of cell stress, such as heat shock
proteins and proteins involved in the extracellular matrix (ECM) like
fibrinogen, heparin sulfate, and hyaluronic acid (Okamura et al. 2001;
Smiley et al. 2001; Cohen-Sfady et al. 2005; Akbarshahi et al. 2011).
Additionally, Wang and Liu recently demonstrated that the SARS-
CoV membrane protein stimulates interferon induction in a TRAF3-
independent manner, using an as yet unknown TLR (Wang and Liu
2016). We have previously shown that extensive ECM remodeling
occurs following SARS-CoV infection (Gralinski et al. 2013), and we
speculate that either ECM changes, or sensing of the SARS-CoV mem-
brane protein, are likely drivers of TLR4 activation.
Mutations in variousTLRs and adapter proteins can have significant
impacts on immunity and susceptibility to infectious diseases.Ticam2 is
required for vesicular stomatitis virus induced TLR4-dependent signal-
ing (Georgel et al. 2007). Three single nucleotide polymorphisms
(SNPs) in Ticam2 were recently shown to be associated with Tubercu-
losis susceptibility, and one SNP was associated with resistance (Hall
et al. 2015). While nonsynonymous mutations in TLRs are rare in
human populations [for example, most mutations in the extracellular
domain of TLR4 are found in ,1% of population (Smirnova et al.
2001)], when observed, they can have a profound effect on the host
response to infection. For example, the relatively common Asp299Gly
mutation in TLR4 has been shown to interfere with recruitment of
MyD88 and TRIF to TLR4, and thus diminish downstream NF-kB-
and IRF3-mediated signaling (Figueroa et al. 2012); individuals with
thismutation aremore prone to septic shock (Lorenz et al. 2002) as well
as Crohn’s disease and ulcerative colitis (Cheng et al. 2015). It was
recently shown that the F protein of respiratory syncytial virus (RSV)
Figure 5 Allele effects. Phenotypes were broken out based on a homozygous CC053/Unc genotype, a homozygous CC003/Unc genotype, or a
heterozygous genotype for day 3 and day 4 weight loss, log10 viral titer, and hemorrhage at the chromosome 18 QTL.
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binds to, and activates, TLR4 (Rallabhandi et al. 2012), and increased
RSV disease severity is associated with the Asp299Gly TLR haplotype
(Caballero et al. 2015).
Ticam2 facilitates the binding of TLR4 and TRIF through the in-
teractionof theTIRdomains of the three proteins (Enokizono et al.2013).
There are four missense mutations between the C57BL/6J and PWK
Ticam2 sequences; however, because the mutations all occur before the
TIR domain, they are unlikely to interfere with Ticam2 binding to either
TLR4 or TRIF. The amino-terminal domain of Ticam2 is less well stud-
ied, but is known to contain both myristoylation and phosphorylation
sites that are essential for Ticam2 to locate to the plasma and endosomal
membranes (Rowe et al. 2006; Kagan et al. 2008). The four Ticam2
missense mutations between PWK and C57BL/6J are predicted to cause
two changes in charge, remove a serine residue, and change a cysteine
residue to a serine (S39 is conserved in mammalian species). Those
mutationsmay alter the structure of the Ticam2 amino-terminal domain,
impact its membrane localization function, or modify the ability of
Ticam2 to properly shuttle TLR4 to the endosome following activation
(Kagan et al. 2008). Finally, the Ticam2 locus is genetically complex,
encoding overlapping negative regulators that could be impacted by these
mutations (Doyle et al. 2012). Thus, there are multiple mechanisms by
which allelic differences in Ticam2 could result in functional conse-
quences in TLR4-mediated signaling and immunity. Importantly, while
our knockout mouse data confirms the role of Ticam2 in helping to
control SARS-CoV mediated disease, it does not prove that allelic vari-
ation in Ticam2 is the cause of the HrS5 phenotypes. Continued work is
needed to address the possible role of other candidate genes in the HrS5
interval, and to assess what, if any, functional changes exist between the
C57BL/6J and PWK Ticam2 alleles.
In conclusion, we utilized two strains of the CC showing extreme
SARS-CoV responses to identify five host genetic loci driving different
aspects of these disease responses. By their design, each CC strain
contains haplotype blocks coming from evolutionarily diverse Mus
musculus substrains. The random sorting of haplotypes that do not
share evolutionary history can give rise to extreme phenotypic re-
sponses within a strain (Rasmussen et al. 2014; Rogala et al. 2014;
Graham et al. 2016) when interacting members of pathways are forced
to work with evolutionarily distinct partners. Diverse subspecific alleles
were present across the five loci within each of the CC lines, strongly
suggesting that the extreme SARS-CoV responses we based our F2
cross on are due, in part, to interactions between alleles from diverse
sets of CC founders. Reinforcing the idea that there might be many
strain-specific interactions that can drive much of the observed varia-
tion in GRPs, in this cross we found evidence for epistatic relationships
across three loci in controlling viral load (Figure 4B).
Importantly, we identified aQTL that contributes tomultiple SARS-
CoV phenotypes, and whole genome sequence analysis pointed to
altered function of the innate-immune modulatory gene Ticam2 as a
strong candidate. Ticam22/2mice were used to confirm the role of that
gene in contributing to SARS-CoV-induced weight loss and pulmonary
hemorrhage, although not vascular cuffing. Knockout mice cannot
address the issue of allelic variation, and thus there is a possibility that
Ticam22/2 mice phenocopy Hrs5, and another gene or genes are re-
sponsible for the SARS-CoV phenotypes that map to chromosome 18.
Use of CRISPR/Cas9 genome editing approaches to swap alleles, rather
than ablate genes, and directly testing specific causal mutations in
extreme CC strains will be a more relevant way to confirm genetic
function in the future. Regardless, this data, along with previously
published work (Sheahan et al. 2008; Totura et al. 2015), combines
to demonstrate that TLR recognition of SARS-CoV infection is a crucial
part of the host immune response to infection. Because allelic variation
in Tlr4 in humans is frequently associated with increased disease
Figure 6 Ticam2 knockouts. Ticam22/2 (n = 14)
and C57BL/6J (n = 12) mice were infected
with 105 PFU of MA15 for 4 d. Weight loss data
(A) confirms our previously published results
(Totura et al. 2015). Vascular cuffing in the lung
was scored in a blinded manner (B) and pulmo-
nary hemorrhage was scored at the time of tis-
sue harvest (C). Asterisks indicate a P value ,
0.05.
1660 | L. E. Gralinski et al.
susceptibility, modulating its signaling through use of agonists or an-
tagonists could allow for effective treatment of a number of disease
states. Testing drug efficacy in a genetically variable population, in-
cluding variation in the pathways of interest, is not possible using
conventional knockout mice. The genetic variation present in the
CC, particularly when it is known to impact functional outcomes such
as SARS-CoV susceptibility, would be a particularly rigorous and ef-
fective test of proposed human therapeutics that modulate TLR
signaling.
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